Significance of prion and prion-like proteins in cancer development, progression and multi-drug resistance

Current Cancer Drug Targets

Volumn 13, Issue 8, 2013, Pages 895-904

  Hinton, Caroline ^a   Antony, Helma ^a,b   Hashimi, Saeed M ^a   Munn, Alan ^a   Wei, Ming Q ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Epigenetic; PRND; PRNP; Protein misfolding; Tumour marker

Indexed keywords

DOPPEL PROTEIN; FILAMIN A; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE; PRION PROTEIN; PROTEIN P53; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ASTROCYTOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; COLORECTAL CANCER; EPIGENETICS; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; MENINGIOMA; METASTASIS; MULTIDRUG RESISTANCE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEOPLASM; NONHUMAN; PANCREAS CANCER; PRION DISEASE; PRION LIKE DOPPLE GENE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STOMACH CANCER;

ANIMALS; DISEASE PROGRESSION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; PRIONS;

EID: 84888112524     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800961131300092     Document Type: Review

References (81)

1. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100 (1), 57-70.
2. Balmain, A.; Gray, J.; Ponder, B., The genetics and genomics of cancer. Nat Genet 2003, 33 (Suppl), 238-244.
3. Anand, P.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Tharakan, S. T.; Lai, O. S.; Sung, B.; Aggarwal, B. B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25 (9), 2097-2116.
4. Pavalko, F. The structure and function of cells. In: Human Physiology 4th edition. Rhoades, R.; Pflanzer, R.; Ed. Thomson learning inc.: USA, 2003; pp 67-107.
5. Sassa, Y.; Kataoka, N.; Inoshima, Y.; Ishiguro, N. Anti-PrP antibodies detected at terminal stage of prion-affected mouse. Cell Immunol. 2010, 263 (2), 212-218.
6. Mehrpour, M.; Codogno, P. Prion protein: From physiology to cancer biology. Cancer Lett. 2010, 290 (1), 1-23.
7. Pammer, J.; Cross, H. S.; Frobert, Y.; Tschachler, E.; Oberhuber, G. The pattern of prion-related protein expression in the gastrointestinal tract. Virchows Archiv: Int. J. Pathol. 2000, 436 (5), 466-472.
8. Liang, J.; Pan, Y.; Zhang, D.; Guo, C.; Shi, Y.; Wang, J.; Chen, Y.; Wang, X.; Liu, J.; Guo, X.; Chen, Z.; Qiao, T.; Fan, D. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS. FASEB J. 2007, 21 (9), 2247-2256.
9. Liang, J.; Pan, Y. L.; Ning, X. X.; Sun, L. J.; Lan, M.; Hong, L.; Du, J. P.; Liu, N.; Liu, C. J.; Qiao, T. D.; Fan, D. M. Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol. 2006, 27 (2), 84-91.
10. Pan, Y.; Zhao, L.; Liang, J.; Liu, J.; Shi, Y.; Liu, N.; Zhang, G.; Jin, H.; Gao, J.; Xie, H.; Wang, J.; Liu, Z.; Fan, D. Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB J. 2006, 20 (11), 1886-1888.
11. Li, C.; Yu, S.; Nakamura, F.; Yin, S.; Xu, J.; Petrolla, A. A.; Singh, N.; Tartakoff, A.; Abbott, D. W.; Xin, W.; Sy, M. S. Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer. J. Clin. Invest. 2009, 119 (9), 2725-2736.
12. Diarra-Mehrpour, M.; Arrabal, S.; Jalil, A.; Pinson, X.; Gaudin, C.; Pietu, G.; Pitaval, A.; Ripoche, H.; Eloit, M.; Dormont, D.; Chouaib, S. Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res. 2004, 64 (2), 719-727.
13. Vassallo, N.; Herms, J.; Behrens, C.; Krebs, B.; Saeki, K.; Onodera, T.; Windl, O.; Kretzschmar, H. A. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival. Biochem. Biophys. Res. Commun. 2005, 332 (1), 75-82.
14. Du, J.; Pan, Y.; Shi, Y.; Guo, C.; Jin, X.; Sun, L.; Liu, N.; Qiao, T.; Fan, D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int. J. Cancer 2005, 113 (2), 213-220.
15. Liang, J.; Ge, F.; Guo, C.; Luo, G.; Wang, X.; Han, G.; Zhang, D.; Wang, J.; Li, K.; Pan, Y.; Yao, L.; Yin, Z.; Guo, X.; Wu, K.; Ding, J.; Fan, D. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. TFEBS J. 2009, 276 (3), 685-694.
16. Han, Z.; Hong, L.; Wu, K.; Han, S.; Shen, H.; Liu, C.; Han, Y.; Liu, Z.; Fan, D. Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA. J. Exp. Clin. Cancer Res. 2006, 25 (4), 601-606.
17. Creutzfeldt, H. Über eine eigenartige herdförmige erkrankung des zentralnervensystems (Vorläufige mitteilung). Z. f. d. g. Neuru. Psych. 1920, 57 (1), 1-18.
18. Liemann, S.; Glockshuber, R. Transmissible Spongiform Encephalopathies. Biochem. Biophys. Res. Comm. 1998, 250 (2), 187-193.
19. DeArmond, S. J.; Bouzamondo, E. Fundamentals of prion biology and diseases. Toxicology 2002, 181-182, 9-16.
20. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216 (4542), 136-144.
21. Sparkes, R. S.; Simon, M.; Cohn, V. H.; Fournier, R. E.; Lem, J.; Klisak, I.; Heinzmann, C.; Blatt, C.; Lucero, M.; Mohandas, T.; et al. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. USA 1986, 83 (19), 7358-7362.
22. Meyer, R. K.; McKinley, M. P.; Bowman, K. A.; Braunfeld, M. B.; Barry, R. A.; Prusiner, S. B. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 1986, 83 (8), 2310-2314.
23. Kim, J. I.; Cali, I.; Surewicz, K.; Kong, Q.; Raymond, G. J.; Atarashi, R.; Race, B.; Qing, L.; Gambetti, P.; Caughey, B.; Surewicz, W. K. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem. 2010, 285 (19), 14083-14087.
24. Luhrs, T.; Ritter, C.; Adrian, M.; Riek-Loher, D.; Bohrmann, B.; Dobeli, H.; Schubert, D.; Riek, R. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 2005, 102 (48), 17342-17347.
25. Sunde, M.; Serpell, L. C.; Bartlam, M.; Fraser, P. E.; Pepys, M. B.; Blake, C. C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 1997, 273 (3), 729-739.
26. Brundin, P.; Melki, R.; Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 2010, 11 (4), 301-307.
27. Aguzzi, A.; Rajendran, L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009, 64 (6), 783-790.
28. Vey, M.; Pilkuhn, S.; Wille, H.; Nixon, R.; DeArmond, S. J.; Smart, E. J.; Anderson, R. G.; Taraboulos, A.; Prusiner, S. B. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. USA 1996, 93 (25), 14945-14949.
29. Sarnataro, D.; Paladino, S.; Campana, V.; Grassi, J.; Nitsch, L.; Zurzolo, C. PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts. Traffic 2002, 3 (11), 810-821.
30. De Simone, A.; Zagari, A.; Derreumaux, P. Structural and hydration properties of the partially unfolded states of the prion protein. Biophys. J. 2007, 93 (4), 1284-1292.
31. Makrinou, E.; Collinge, J.; Antoniou, M. Genomic characterization of the human prion protein (PrP) gene locus. Mamm. Genome 2002, 13 (12), 696-703.
32. Linden, R.; Martins, V. R.; Prado, M. A.; Cammarota, M.; Izquierdo, I.; Brentani, R. R. Physiology of the prion protein. Physiol. Rev. 2008, 88 (2), 673-728.
33. Stewart, R. S.; Harris, D. A. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J. Biol. Chem. 2003, 278 (46), 45960-45968.
34. Welker, E.; Raymond, L. D.; Scheraga, H. A.; Caughey, B. Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 2002, 277 (36), 33477-33481.
35. Hooper, N. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem. Soc. F. Trans. 2005, 33, 335-338.
36. Mange, A.; Beranger, F.; Peoc'h, K.; Onodera, T.; Frobert, Y.; Lehmann, S. Alpha-and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell 2004, 96 (2), 125-132.
37. Vincent, B.; Paitel, E.; Frobert, Y.; Lehmann, S.; Grassi, J.; Checler, F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 2000, 275 (45), 35612-35616.
38. Jimenez-Huete, A.; Lievens, P. M.; Vidal, R.; Piccardo, P.; Ghetti, B.; Tagliavini, F.; Frangione, B.; Prelli, F. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol. 1998, 153 (5), 1561-1572.
39. Pan, K. M.; Stahl, N.; Prusiner, S. B. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci. 1992, 1 (10), 1343-1352.
40. Nieznanski, K.; Nieznanska, H.; Skowronek, K. J.; Osiecka, K. M.; Stepkowski, D. Direct interaction between prion protein and tubulin. Biochem. Biophys. Res. Commun. 2005, 334 (2), 403-411.
41. Watt, N. T.; Taylor, D. R.; Gillott, A.; Thomas, D. A.; Perera, W. S.; Hooper, N. M. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 2005, 280 (43), 35914-35921.
42. Taraboulos, A.; Raeber, A. J.; Borchelt, D. R.; Serban, D.; Prusiner, S. B. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 1992, 3 (8), 851-863.
43. Llorens, F.; Del Rio, J. A. Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity. Prion 2012, 6 (3), 245-251.
44. Westergard, L.; Christensen, H. M.; Harris, D. A. The cellular prion protein (PrP(C): its physiological function and role in disease. Biochimica. Biophysica. Acta. 2007, 1772 (6), 629-644.
45. McLennan, N. F.; Rennison, K. A.; Bell, J. E.; Ironside, J. W. In situ hybridization analysis of PrP mRNA in human CNS tissues. Neuropathol. Appl. Neurobiol. 2001, 27 (5), 373-383.
46. Brown, H. R.; Goller, N. L.; Rudelli, R. D.; Merz, G. S.; Wolfe, G. C.; Wisniewski, H. M.; Robakis, N. K. The mRNA encoding the scrapie agent protein is present in a variety of non-neuronal cells. Acta. Neuropathologica. 1990, 80 (1), 1-6.
47. Haeberle, A. M.; Ribaut-Barassin, C.; Bombarde, G.; Mariani, J.; Hunsmann, G.; Grassi, J.; Bailly, Y. Synaptic prion protein immuno-reactivity in the rodent cerebellum. Microscopy Res. Tech. 2000, 50 (1), 66-75.
48. Laine, J.; Marc, M. E.; Sy, M. S.; Axelrad, H. Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur. J. Neurosci. 2001, 14 (1), 47-56.
49. Comincini, S.; Facoetti, A.; Del Vecchio, I.; Peoc'h, K.; Laplanche, J. L.; Magrassi, L.; Ceroni, M.; Ferretti, L.; Nano, R. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. Anticancer Res. 2004, 24 (3a), 1507-1517.
50. Brazil, D. P.; Park, J.; Hemmings, B. A. PKB binding proteins. Getting in on the Akt. Cell 2002, 111 (3), 293-303.
51. Vivanco, I.; Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2002, 2 (7), 489-501.
52. Wang, J. H.; Du, J. P.; Li, S. J.; Zhai, L. P.; Yang, X. Y.; Wang, Z. H.; Wu, Z. T.; Han, Y. Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells. J. Dig. Dis. 2012, 13 (3), 143-152.
53. Zhao, Y.; You, H.; Liu, F.; An, H.; Shi, Y.; Yu, Q.; Fan, D. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett. 2002, 185 (2), 211-218.
54. Juranka, P. F.; Zastawny, R. L.; Ling, V. P-glycoprotein: multidrugresistance and a superfamily of membrane-associated transport proteins. FASEBJ 1989, 3 (14), 2583-2592.
55. Wang, J. H.; Du, J. P.; Zhang, Y. H.; Zhao, X. J.; Fan, R. Y.; Wang, Z. H.; Wu, Z. T.; Han, Y. Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance. World J. Gastroenterol. 2011, 17 (35), 3986-3993.
56. Chattopadhyay, M.; Walter, E. D.; Newell, D. J.; Jackson, P. J.; Aronoff-Spencer, E.; Peisach, J.; Gerfen, G. J.; Bennett, B.; Antholine, W. E.; Millhauser, G. L. The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7. 4. J. Am. Chem. Soc. 2005, 127 (36), 12647-12656.
57. Han, H.; Bearss, D. J.; Browne, L. W.; Calaluce, R.; Nagle, R. B.; Von Hoff, D. D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002, 62 (10), 2890-2896.
58. Li, C.; Xin, W.; Sy, M. S. Binding of pro-prion to filamin A: by design or an unfortunate blunder. Oncogene 2010, 29 (39), 5329-5345.
59. Meslin, F.; Hamai, A.; Gao, P.; Jalil, A.; Cahuzac, N.; Chouaib, S.; Mehrpour, M. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res. 2007, 67 (22), 10910-10919.
60. Li, Q. Q.; Cao, X. X.; Xu, J. D.; Chen, Q.; Wang, W. J.; Tang, F.; Chen, Z. Q.; Liu, X. P.; Xu, Z. D. The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel. Cell. Mol. Life Sci CMLS 2009, 66 (3), 504-515.
61. Roucou, X.; Giannopoulos, P. N.; Zhang, Y.; Jodoin, J.; Goodyer, C. G.; LeBlanc, A. Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 2005, 12 (7), 783-795.
62. Antonacopoulou, A. G.; Grivas, P. D.; Skarlas, L.; Kalofonos, M.; Scopa, C. D.; Kalofonos, H. P. POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance? Anticancer Res. 2008, 28 (2B), 1221-1227.
63. Antonacopoulou, A. G.; Palli, M.; Marousi, S.; Dimitrakopoulos, F. I.; Kyriakopoulou, U.; Tsamandas, A. C.; Scopa, C. D.; Papavassiliou, A. G.; Kalofonos, H. P. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer. Mol. Carcinog. 2010, 49 (7), 693-699.
64. McEwan, J. F.; Windsor, M. L.; Cullis-Hill, S. D. Antibodies to prion protein inhibit human colon cancer cell growth. Tumour Biol. 2009, 30 (3), 141-147.
65. Yap, Y. H.; Say, Y. H. Resistance against apoptosis by the cellular prion protein is dependent on its glycosylation status in oral HSC-2 and colon LS 174T cancer cells. Cancer Lett. 2011, 306 (1), 111-119.
66. Sauer, H.; Dagdanova, A.; Hescheler, J.; Wartenberg, M. Redoxregulation of intrinsic prion expression in multicellular prostate tumor spheroids. Free Radic. Biol. Med. 1999, 27 (11-12), 1276-1283.
67. Silverman, G. L.; Qin, K.; Moore, R. C.; Yang, Y.; Mastrangelo, P.; Tremblay, P.; Prusiner, S. B.; Cohen, F. E.; Westaway, D. Doppel is an N-glycosylated, glycosylphosphatidylinositolanchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. J. Biol. Chem. 2000, 275 (35), 26834-26841.
68. Moore, R. C.; Lee, I. Y.; Silverman, G. L.; Harrison, P. M.; Strome, R.; Heinrich, C.; Karunaratne, A.; Pasternak, S. H.; Chishti, M. A.; Liang, Y.; Mastrangelo, P.; Wang, K.; Smit, A. F.; Katamine, S.; Carlson, G. A.; Cohen, F. E.; Prusiner, S. B.; Melton, D. W.; Tremblay, P.; Hood, L. E.; Westaway, D. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 1999, 292 (4), 797-817.
69. Peoc'h, K.; Volland, H.; De Gassart, A.; Beaudry, P.; Sazdovitch, V.; Sorgato, M. C.; Creminon, C.; Laplanche, J. L.; Lehmann, S. Prion-like protein Doppel expression is not modified in scrapieinfected cells and in the brains of patients with Creutzfeldt-Jakob disease. FEBS Lett. 2003, 536 (1-3), 61-65.
70. Mastrangelo, P.; Westaway, D. The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis. Gene 2001, 275 (1), 1-18.
71. Luhrs, T.; Riek, R.; Guntert, P.; Wuthrich, K. NMR structure of the human doppel protein. J. Mol. Biol. 2003, 326 (5), 1549-1557.
72. Peoc'h, K.; Serres, C.; Frobert, Y.; Martin, C.; Lehmann, S.; Chasseigneaux, S.; Sazdovitch, V.; Grassi, J.; Jouannet, P.; Launay, J. M.; Laplanche, J. L. The human "prion-like" protein Doppel is expressed in both Sertoli cells and spermatozoa. J. Biol. Chem. 2002, 277 (45), 43071-43078.
73. Behrens, A.; Aguzzi, A. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl. Trends Neurosci. 2002, 25 (3), 150-154.
74. Travaglino, E.; Comincini, S.; Benatti, C.; Azzalin, A.; Nano, R.; Rosti, V.; Ferretti, L.; Invernizzi, R. Overexpression of the Doppel protein in acute myeloid leukaemias and myelodysplastic syndromes. Br. J. Haematol. 2005, 128 (6), 877-884.
75. Stone, R. M.; O'Donnell, M. R.; Sekeres, M. A. Acute myeloid leukemia. Hematology Am. Soc. Hematol. Educ. Program 2004, 98-117.
76. Rubnitz, J. E.; Gibson, B.; Smith, F. O. Acute myeloid leukemia. Pediatr. Clin. North Am. 2008, 55 (1), 21-51.
77. De, S., Lurquin, C., Lethe, B., Martelange, V., Boon, T. DNA methylation is the primary silencing mechanism for a set of germ line-and tumor-specific genes with a CpG-rich promoter. Mol. Cell Biol. 1999, 19, 7327-7335.
78. Chen, F.; Wang, W.; El-Deiry, W. S. Current strategies to target p53 in cancer. Biochem. Pharmacol. 2010, 80 (5), 724-730.
79. Xu, J.; Reumers, J.; Couceiro, J. R.; De Smet, F.; Gallardo, R.; Rudyak, S.; Cornelis, A.; Rozenski, J.; Zwolinska, A.; Marine, J. C.; Lambrechts, D.; Suh, Y. A.; Rousseau, F.; Schymkowitz, J. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat. Chem. Biol. 2011, 7 (5), 285-295.
80. Brown, C. J.; Lain, S.; Verma, C. S.; Fersht, A. R.; Lane, D. P. Awakening guardian angels: drugging the p53 pathway. Nat. Rev. Cancer 2009, 9 (12), 862-873.
81. Ano Bom, A. P.; Rangel, L. P.; Costa, D. C.; de Oliveira, G. A.; Sanches, D.; Braga, C. A.; Gava, L. M.; Ramos, C. H.; Cepeda, A. O.; Stumbo, A. C.; De Moura Gallo, C. V.; Cordeiro, Y.; Silva, J. L. Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer. J. Biol. Chem. 2012, 287 (33), 28152-28162.